Royal Bank of Canada »

Perspective Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-06-30 $44k 4.4k 9.93

More positions owned by Royal Bank of Canada

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A (GOOGL)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Bk Nova Cad (BNS)
Enbridge (ENB)
Visa Com Cl A (V)

View all positions for Royal Bank of Canada

Top funds holding Perspective Therapeutics

Commodore Capital
Henderson Group
BlackRock
Avidity Partners Management
Vanguard Group
Deerfield Management Company
Nicholson Wealth Management Group
Octagon Capital Advisors
Marshall Wace
Geode Capital Management
Hills Bank And Trust Company
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors
Sphera Funds Management

View all funds holding Perspective Therapeutics